Patents by Inventor Howard E. Greene

Howard E. Greene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES
    Publication number: 20100130472
    Abstract: Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes.
    Type: Application
    Filed: November 23, 2009
    Publication date: May 27, 2010
    Applicant: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Andrew A. YOUNG, Bronislava GEDULIN, Howard E. GREENE
  • COMPOSITIONS CONTAINING SATIOGENS AND METHODS OF USE
    Publication number: 20100130426
    Abstract: Provided herein are methods and compositions for treating metabolic diseases and conditions associated with metabolic diseases.
    Type: Application
    Filed: November 23, 2009
    Publication date: May 27, 2010
    Applicant: SATIOGEN PHARMACEUTICALS, INC.
    Inventors: Andrew A. YOUNG, Bronislava GEDULIN, Howard E. GREENE
  • Immunometric assays using monoclonal antibodies
    Patent number: 4486530
    Abstract: "Two-site" or "sandwich" immunometric assay techniques for determination of the presence and/or concentration of antigenic substances in fluids using monoclonal antibodies are described and compared to conventional assays using polyclonal antibodies. Also described are inhibition assays using complexes of antigens with a monoclonal antibody.
    Type: Grant
    Filed: June 24, 1981
    Date of Patent: December 4, 1984
    Assignee: Hybritech Incorporated
    Inventors: Gary S. David, Howard E. Greene
  • Immunometric assays using monoclonal antibodies
    Patent number: 4376110
    Abstract: "Two-site" or "sandwich" immunometric assay techniques for determination of the presence and/or concentration of antigenic substances in fluids using monoclonal antibodies. One monoclonal antibody is presented in a soluble labeled form and a second monoclonal antibody is presented bound to a solid carrier; the soluble and bound monoclonal antibodies may be the products of either the same or different cell lines. Each monoclonal antibody has an affinity for the antigenic substances of at least about 10.sup.8 liters/mole.
    Type: Grant
    Filed: August 4, 1980
    Date of Patent: March 8, 1983
    Assignee: Hybritech, Incorporated
    Inventors: Gary S. David, Howard E. Greene